Harnessing the power of prevention: human papillomavirus vaccines

Current Opinion in Obstetrics & Gynecology
Edward J Mayeaux

Abstract

Human papillomavirus (HPV) infection and HPV-associated diseases pose a considerable health care burden in the United States. The morbidity and mortality associated with HPV infection and HPV-associated diseases, ranging from genital warts to cervical cancer, have prompted both the use of screening measures to monitor HPV infection and the development of numerous treatment modalities to address its clinical sequelae. Although screening programs have dramatically reduced the incidence of cervical cancer through early detection and treatment, this devastating illness, which frequently affects women of reproductive age, remains a major public health concern. Prophylactic vaccines that prevent HPV infection have proved to be safe, well tolerated, highly efficacious, and induce long-lasting immunity to HPV. Multivalent vaccines that protect against the most common disease-causing HPV types should significantly reduce the morbidity and mortality associated with HPV.

References

Jan 1, 1988·Epidemiologic Reviews·L A KoutskyK K Holmes
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel
May 1, 1997·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·R HerreroL A Brinton
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Mar 16, 2000·Journal of the National Cancer Institute·R HerreroM Schiffman
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L R ArmstrongW C Reeves
Oct 24, 2000·Obstetrics and Gynecology·D L DellD E Stewart
May 4, 2002·JAMA : the Journal of the American Medical Association·Jeanne S MandelblattKeerti Shah
Nov 22, 2002·The New England Journal of Medicine·Laura A KoutskyUNKNOWN Proof of Principle Study Investigators
Jan 21, 2003·Emerging Infectious Diseases·Gillian D Sanders, Al V Taira
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ralph P InsingaEvan R Myers
Jun 17, 2003·Journal of the National Cancer Institute. Monographs·F Xavier Bosch, Silvia de Sanjosé
Jun 17, 2003·Journal of the National Cancer Institute. Monographs·Mark Schiffman, Susanne Krüger Kjaer
Aug 7, 2003·Journal of the National Cancer Institute·Denise Nardelli-HaefligerPierre De Grandi
Jan 30, 2004·Annual Review of Medicine·Kathrin U Jansen, Alan R Shaw
Mar 12, 2004·The Journal of the American Board of Family Practice·Bryan HolcombMack T Ruffin
Mar 20, 2004·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·M Concepción BrattiRolando Herrero
Mar 20, 2004·Nature Reviews. Microbiology·John T Schiller, Philip Davies
Aug 6, 2004·American Journal of Obstetrics and Gynecology·Ralph P InsingaBrenda B Rush
Sep 17, 2004·CA: a Cancer Journal for Clinicians·Diane M Harper
Nov 20, 2004·Emerging Infectious Diseases·Al V TairaGillian D Sanders
Dec 21, 2004·The Journal of Infectious Diseases·Darron R BrownJ Dennis Fortenberry

❮ Previous
Next ❯

Citations

Nov 10, 2010·Protein Expression and Purification·So Young KimHong-Jin Kim
Jul 4, 2006·Nature Reviews. Drug Discovery·Grzegorz NalepaJ Wade Harper
Dec 2, 2006·Sexually Transmitted Diseases·Mary A GerendJanet E Shepherd
Apr 13, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kakoli BoseJames D Baleja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.